This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Aug;27(7):699-703.

doi: 10.1080/07357900903152473.

Pharmacogenetics of breast cancer: toward the individualization of therapy

Jenny C Chang¹, Susan G Hilsenbeck, Suzanne A W Fuqua

Affiliations

PMID: 19637041
DOI: 10.1080/07357900903152473

Pharmacogenetics of breast cancer: toward the individualization of therapy

Jenny C Chang et al. Cancer Invest. 2009 Aug.

. 2009 Aug;27(7):699-703.

doi: 10.1080/07357900903152473.

Authors

Jenny C Chang¹, Susan G Hilsenbeck, Suzanne A W Fuqua

Affiliation

¹ Breast Center, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.

PMID: 19637041
DOI: 10.1080/07357900903152473

No abstract available

PubMed Disclaimer

Similar articles

Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, Jin WR, Shao ZM. Li LF, et al. Breast Cancer Res Treat. 2009 Jan;113(2):231-7. doi: 10.1007/s10549-008-9925-4. Epub 2008 Feb 16. Breast Cancer Res Treat. 2009. PMID: 18278552
High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.
Moiseyenko VM, Protsenko SA, Brezhnev NV, Maximov SY, Gershveld ED, Hudyakova MA, Lobeiko OS, Gergova MM, Krzhivitskiy PI, Semionov II, Matsko DE, Iyevleva AG, Sokolenko AP, Sherina NY, Kuligina ESh, Suspitsin EN, Togo AV, Imyanitov EN. Moiseyenko VM, et al. Cancer Genet Cytogenet. 2010 Feb;197(1):91-4. doi: 10.1016/j.cancergencyto.2009.10.003. Cancer Genet Cytogenet. 2010. PMID: 20113845 No abstract available.
Molecular assays to predict prognosis of breast cancer.
Paik S. Paik S. Clin Adv Hematol Oncol. 2007 Sep;5(9):681-2. Clin Adv Hematol Oncol. 2007. PMID: 17982408 Review. No abstract available.
Personalized systemic treatment for breast cancer patients: is it a reality?
Shimizu C, Fujiwara Y. Shimizu C, et al. Breast Cancer. 2008;15(2):141-4. doi: 10.1007/s12282-008-0029-0. Breast Cancer. 2008. PMID: 18274835 Review.
Antiangiogenic therapy in patients with HER2-positive metastatic breast cancer: a case series.
Le Saux O, You B, Freyer G. Le Saux O, et al. Clin Breast Cancer. 2014 Jun;14(3):e89-94. doi: 10.1016/j.clbc.2013.11.005. Epub 2013 Nov 21. Clin Breast Cancer. 2014. PMID: 24424314 No abstract available.

See all similar articles

Cited by

Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.
Song X, Zhang C, Zhao M, Chen H, Liu X, Chen J, Lonard DM, Qin L, Xu J, Wang X, Li F, O'Malley BW, Wang J. Song X, et al. PLoS One. 2015 Oct 2;10(10):e0140011. doi: 10.1371/journal.pone.0140011. eCollection 2015. PLoS One. 2015. PMID: 26431029 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information